D N (Israel) Financial Indicators Patterns

DNA -- Israel Stock  

ILS 24.70  0.90  3.52%

Use fundamental data analysis to check all available reported financial drivers of D N A to find out if markets are at this moment mispricing the company. We found twenty-three available fundamental indicators for D N A Biomedical Solutions Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all D N A fundamentals including its Cash and Equivalents, Beta, Current Liabilities, as well as the relationship between Cash Flow from Operations and Retained Earnings . Use D N to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of D N to be traded at S23.71 in 30 days

D N Company Summary

D N competes with Kamada Ltd, Compugen Ltd, Evogene Ltd, and BioLight Life. D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is based in Ramat Gan, Israel. D N operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.

D N Current Asset vs Total Asset

D N A Biomedical Solutions Ltd is rated # 5 in current asset category among related companies. It is rated # 5 in total asset category among related companies fabricating about  1.62  of Total Asset per Current Asset.

D N A Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on D N A correlated with the market. If Beta is less than 0 D N generally moves in the opposite direction as compared to the market. If D N Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one D N A is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of D N is generally in the same direction as the market. If Beta > 1 D N moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

D N Financial Distress Probability

90%
Chance of Financial Distress
D N A Biomedical Solutions Ltd has more than 90 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare D N

Compare D N To Peers

D N Opportunity Range

December 17, 2018 Opportunity Range

Additionally see Investing Opportunities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com